AIM Self-Assessment: Volume Two

Price: $199 for College Members, $299 for non-members

College membership is free for Fellows-in-Training

You can earn up to 24 AMA PRA Category 1 Credit(s). 

This second Allergy & Immunology Medicine self-assessment module is designed to help allergy/immunology providers obtain new knowledge, as well as reaffirm existing knowledge. It also helps allergists/immunologists evaluate and maintain their clinical competence. The module consists of 120 all new case-based, multiple-choice questions. Comprehensive discussions provide evidence-based explanations regarding all answer options, as well as provides supporting references from the current literature. The questions address five categories (allergy and hypersensitivity, immunological disorders, immune system/research, pharmacology/therapeutics, and allergens/antigens/extracts.

There are 4 modes within this module: Pretest, Learn, Posttest and Comparison.

Pretest: This initial self-audit allows for one to identify their gaps in knowledge related to established knowledge in allergy and immunology. Answer each question once and receive a Pretest Score at the end.

Learn: This study mode allows one to answer questions, review evidence-based discussions, and link to PubMed abstracts of the references. Answer each question until the correct answer is chosen, then read the discussion and view the references. If you answer incorrectly, you will be given a brief statement on why that answer choice is incorrect. The comprehensive discussion includes rationale for all answer options, whether they are correct or incorrect.

Posttest: This final audit allows one to measure the amount of learning that has occurred. Answer each question once and receive a Posttest Score at the end. One has 3 attempts to achieve a passing score of 80% or better.

Comparison: This final mode provides a comparison chart showing one’s pretest vs posttest scores, and a peer-to-peer comparison that shows how one compares to their colleagues answering the same questions.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 24 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAI designates this program for 24 ABAI MOC Part II (Self-Assessment) credits.

Commercial Support
There is no commercial support for this activity.

Target Audience

Practicing Allergy/Immunology Providers and Fellows in Training.

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Identify, evaluate and manage current concerns and issues related to the pathophysiology, diagnosis and treatment of allergic and immunologic diseases
  • Demonstrate a mastery of key concepts in allergy and immunology
  • Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

Course summary
Available credit: 
  • 24.00 AMA PRA Category 1 Credit™
  • 24.00 Attendance
  • 24.00 MOC
Course opens: 
07/20/2022
Course expires: 
07/19/2023
Cost:
$99,999,999.00
Rating: 
0

Gerald Lee, MD Editor in Chief
Dr. Lee is an associate professor of pediatrics and internal medicine at Emory University School of Medicine. He has multiple roles in medical education, including allergy/immunology fellowship program director, medical school immunology thread director, and editor in chief of the ACAAI AIM Self-Assessment and Board Review Book.
Disclosures: Nothing to disclose

Tracy B. Fausnight, MD
Division Chief, Pediatric Allergy and Immunology, Penn State Health Children's Hospital 
Associate Training Program Director, Allergy and Immunology Fellowship Program
Professor of Pediatrics and Medicine, Penn State College of Medicine 
Disclosures: Researcher: Chiesi

Justin Greiwe, MD
Bernstein Allergy Group Inc, Cincinnati, OH; Division of Immunology/Allergy Section, Department of Internal Medicine, The University of Cincinnati College of Medicine, Cincinnati, OH
Disclosures: Speaking/Teaching Honorarium: AstraZeneca; Sanofi Genzyme & Regeneron; Incyte   
Advising/Consulting Fee: ALK, AstraZeneca; Sanofi Genzyme & Regeneron

William J. Lavery, MD, PhD
Dr. Lavery is a board-certified allergist/immunologist and board-certified pediatrician in private clinical practice with Kansas City Allergy and Asthma and a principal investigator with Meridian Clinical Research in Overland Park, Kansas. He is currently a member of the ACAAI's Biologics and Pharmacology Committee and Education Services, Data & Technology Committee.
Disclosures: Nothing to disclose

Merin Kalangara, MD
Emory University School of Medicine
Atlanta, GA
Disclosures: Consultant: Sanofi
Speaker: GlaxoSmithKline

Min Jung Lee, MD
Hoag Medical Group 
Newport Beach, CA
Disclosures: Nothing to disclose

Pavadee Poowuttikul, MD
Children’s Hospital of Michigan
Detroit, MI
Disclosures: Nothing to disclose

Benjamin T. Prince, MD, MSCI
Associate Professor of Pediatrics
Division of Allergy-Immunology
Nationwide Children's Hospital
The Ohio State University College of Medicine
Disclosures: Nothing to disclose

Eric Schauberger, DO, PhD
Dr Schauberger is an Allergist/Immunologist in the Department of Pediatrics at the University of Wisconsin-Madison. Eric’s clinical interest is in pediatric food allergy, asthma and penicillin allergy. His research focus includes the origins and early life risk factors for the development of allergy and asthma. He is the Associate Program Director at the UW Allergy/Immunology Fellowship program.
Disclosures: Nothing to disclose

Jennifer Shih, MD
Dr. Jennifer Shih is an Assistant Professor in the Department of Medicine and Pediatrics at Emory University. She was the Medical Director of the pediatric allergy clinics until 2020 and the Associate Director of the adult asthma, allergy and immunology program. She is the current president of the Allergy, Asthma, and Immunology Society of Georgia and gives talks both regionally and nationally. 
Disclosures: Advisor: ALK, Pharming Group

Kristin Sokol, MD, MS, MPH
Allergist/immunologist 
Schreiber Allergy
Rockville, MD  
Disclosures: Speaker/Teaching Honorarium: Sanofi Genzyme, AstraZeneca

Gregory R. Toci, DO
Dr. Toci is in private clinical practice with Advocare Allergy & Asthma in Marlton, New Jersey. He is currently a member of the ACAAI Accreditation & Certification Committee and previously was a member of the ACAAI and AAAAI Sports Medicine Committees. 
Disclosures: Speaker/Teaching Honorarium: Sanofi Aventis, Regeneron
 

Available Credit

  • 24.00 AMA PRA Category 1 Credit™
  • 24.00 Attendance
  • 24.00 MOC

Price

Cost:
$99,999,999.00
Please login or create an account to take this course.